日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neuroleptic malignant syndrome in a patient with COVID-19 and the possible role of SARS-CoV-2 in its manifestation: case report and overview of published cases

一例合并 COVID-19 的神经阻滞剂恶性综合征及其 SARS-CoV-2 可能发挥的作用:病例报告及已发表病例综述

Skront, Tomas; Sagan, Jiri; Hyza, Martin

Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN)

评估 rTMS 辅助治疗对改善精神分裂症阴性症状价值的试验的理论依据和研究设计 (RADOVAN)

Hebel, T; Langguth, B; Schecklmann, M; Schoisswohl, S; Staudinger, S; Schiller, A; Ustohal, L; Sverak, T; Horky, M; Kasparek, T; Skront, T; Hyza, M; Poeppl, T B; Riester, M L; Schwemmer, L; Zimmermann, S; Sakreida, K